Benzinga - Thu, 25 Feb 2021 13:35:09 -0400
Benzinga - Wed, 24 Feb 2021 14:02:11 -0400
Benzinga - Wed, 24 Feb 2021 13:20:48 -0400
Benzinga - Wed, 24 Feb 2021 08:04:15 -0400
Benzinga - Wed, 24 Feb 2021 06:01:42 -0400
Benzinga - Tue, 23 Feb 2021 17:37:20 -0400
Benzinga - Tue, 23 Feb 2021 13:33:56 -0400
Benzinga - Wed, 10 Feb 2021 11:23:13 -0400
load more
Sector: Health Care.Industry: Biotechnology
Solid Biosciences Inc is a life science company. It is engaged in manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Its lead product candidate, the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices. In the assistive device program, the company focuses on producing a wearable assistive device for patients with DMD.

Earnings

see more
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-03-11
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
SLDBSolid Biosciences-13.03%679M

Solid Biosciences Company Questions & Answers

Q

How do I buy Solid Biosciences (SLDB) stock?

A

You can purchase shares of Solid Biosciences (NASDAQ: SLDB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Solid Biosciences's (SLDB) main competitors?

A

Other companies in Solid Biosciences’s space includes: KalVista Pharmaceuticals (NASDAQ:KALV), Curis (NASDAQ:CRIS) and Chinook Therapeutics (NASDAQ:KDNY).

Q

What is the target price for Solid Biosciences?

A

The latest price target for Solid Biosciences (NASDAQ: SLDB) was reported by Credit Suisse on 2021-01-08. The analyst firm set a price target for 7.00 expecting SLDB to fall to within 12 months (a possible -12.61% downside). 4 analyst firms have reported ratings in the last year.

Q

How much is Solid Biosciences (SLDB) stock ?

A

The stock price for Solid Biosciences (NASDAQ: SLDB) is $8.01 last updated Thu Feb 25 2021 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Solid Biosciences (SLDB) dividend?

A

There are no upcoming dividends for Solid Biosciences.

Q

When is Solid Biosciences (NASDAQ:SLDB) reporting earnings?

A
Solid Biosciences’s Q4 earnings are confirmed after-market from now on March 11, 2021.
Q

When is the upcoming split for SLDB?

A

There is no upcoming split for Solid Biosciences.